Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study
Introduction The use of immune checkpoint inhibitors (ICIs) is rapidly expanding in cancer treatment. ICIs have a unique safety profile, characterised by immune-related adverse events (irAEs). The safety profile of ICIs lacks patient experience and perspectives. This study primarily aims to obtain a...
Saved in:
| Main Authors: | Takuhiro Yamaguchi, Tempei Miyaji, Takashi Kawaguchi, Kanako Azuma, Taiki Hirata, Ayako Torii, Hiroaki Usui, Soan Kim, Tatsuya Hayama, Daisuke Hirate, Yosuke Kawahara, Yuki Kumihashi, Tomomi Chisaka, Tetsuya Wako, Akinobu Yoshimura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/11/e073724.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nurse‐Led Screening‐Triggered Early Specialized Palliative Care Program for Patients With Advanced Lung Cancer: A Multicenter Randomized Controlled Trial
by: Yoshihisa Matsumoto, et al.
Published: (2024-11-01) -
Resolvins as Regulators of the Immune System
by: Hiroyuki Seki, et al.
Published: (2010-01-01) -
Contradictory Immune Response in Post Liver Transplantation Hepatitis B and C
by: Akinobu Takaki, et al.
Published: (2014-01-01) -
Regulatory T Cell Immunity in Atherosclerosis
by: Hilman Zulkifli Amin, et al.
Published: (2017-05-01) -
Regulatory T Cell Immunity in Atherosclerosis
by: Hilman Zulkifli Amin, et al.
Published: (2017-05-01)